BRIEF published on 07/22/2024 at 12:42, 2 months 6 days ago Results of the Novacyt Annual General Meeting Nomination Resolutions General Assembly Molecular Diagnostics Novacyt
BRIEF published on 07/22/2024 at 12:41, 2 months 6 days ago Novacyt Announces AGM Results and New Board Appointments AGM Executive Directors Molecular Diagnostics Board Appointments Novacyt
PRESS RELEASE published on 07/22/2024 at 12:36, 2 months 6 days ago Result of AGM Novacyt S.A. announces successful AGM with new Executive Directors. Visit the company's website for AGM voting results Voting Results AGM Executive Directors Molecular Diagnostics Novacyt
BRIEF published on 07/18/2024 at 12:40, 2 months 10 days ago Novacyt announces the financial impacts of the agreement with DHSC Treasury VAT Financial Agreement Novacyt DHSC
BRIEF published on 07/18/2024 at 12:38, 2 months 10 days ago Novacyt Announces Financial Impact of DHSC Settlement Financial Impact Novacyt DHSC Settlement VAT Reclaim Clinical Diagnostics
PRESS RELEASE published on 07/18/2024 at 12:33, 2 months 10 days ago AGM Statement on Impact of DHSC Settlement Novacyt provides update on AGM statement regarding DHSC settlement impact, anticipating a potential £7m net cash increase from VAT reclaim. Details of income statement and cash flow implications disclosed Novacyt DHSC Settlement VAT Reclaim AGM Statement Net Cash Increase
BRIEF published on 06/26/2024 at 15:40, 3 months 2 days ago Novacyt Reschedules AGM to 18 July Shareholders AGM Novacyt Online Meeting Rescheduled
PRESS RELEASE published on 06/26/2024 at 15:35, 3 months 2 days ago Notice of rescheduled AGM Novacyt S.A. announces rescheduling of AGM to be held online on 18 July. Shareholders can register to view the meeting via the online platform. Full details to follow. Contact information provided Annual General Meeting Shareholders Novacyt S.A. Online Meeting Rescheduled
BRIEF published on 06/14/2024 at 11:53, 3 months 14 days ago Publication of the annual report of Novacyt SA Technologies Annual Report 2023 Novacyt Molecular Diagnosis Integrated Services
BRIEF published on 06/14/2024 at 11:51, 3 months 14 days ago Novacyt Publishes Annual Report for 2023 Financial Results Annual Report Molecular Diagnostics Novacyt
Published on 09/28/2024 at 02:06, 1 day 9 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 9 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 11 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 21 hours 29 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 13 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 13 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 16 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 17 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 17 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024